1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: China Medical Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. China Medical Devices Market Revenue and Volume, By Type
8.1.1 In-Vitro Diagnostics (IVD)
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Diagnostic Imaging
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Medical Consumables
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Cardiovascular Devices
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Orthopedic Devices
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Therapeutic & Others
8.1.6.1. Market Revenue and Volume Forecast
9.1. China Medical Devices Market Revenue and Volume, By End-User
9.1.1. Hospitals & ASCs
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Clinics & Diagnostic Centers
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Homecare Settings
9.1.3.1. Market Revenue and Volume Forecast
10.1 China
10.1.1. Market Revenue and Volume Forecast, By Type
10.1.2.1. Market Revenue and Volume Forecast, By End-User
11.1. MicroPort Scientific
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Lepu Medical
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Yuwell (Yuyue Medical)
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Biolight Medtech
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Snibe Diagnostic
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Blue Sail Medical
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Autobio Diagnostics
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Wandfu Biotech
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. APT Medical
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Lepu Medical
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
